Salix Coronary Plaque vs Viz HCM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Salix Coronary Plaque

by Artrya

Viz HCM

by Viz.ai

AI Verdict

While both tools leverage AI in cardiology, they address distinct conditions and utilize different diagnostic modalities. Salix Coronary Plaque focuses on detecting and quantifying coronary artery plaque and stenosis from CCTA scans for Coronary Artery Disease, whereas Viz HCM uses ECG analysis to detect suspected Hypertrophic Cardiomyopathy and coordinate care. Therefore, their applicability depends on the specific cardiac condition being investigated.

Choose Salix Coronary Plaque if…

Choose Salix Coronary Plaque if your institution requires an AI-driven, web-based solution for the rapid and comprehensive analysis of CCTA scans. This tool is ideal for cardiologists and radiologists seeking near real-time, point-of-care assessment of coronary artery plaque, including high-risk features and stenosis, to inform immediate diagnostic and treatment strategies for coronary artery disease.

View Salix Coronary Plaque →

Choose Viz HCM if…

Choose Viz HCM if your primary goal is the early and efficient detection of suspected Hypertrophic Cardiomyopathy (HCM) from routine ECGs across your health system. This AI-powered tool excels at real-time identification of potential HCM cases, automating alerts to multidisciplinary care teams and streamlining patient pathways to specialists, thereby significantly reducing diagnosis time and improving care coordination for this specific condition.

View Viz HCM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Salix Coronary Plaque	Viz HCM
Pricing	Subscription model	Unknown
Deployment	Cloud-based (Amazon Web Services), web-based software application	Unknown
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Salix Coronary Plaque	Viz HCM
Product Name	Salix Coronary Plaque	Viz HCM
Company	Artrya Limited	Viz.ai
Primary Function	AI-driven, web-based software for near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans.	AI tool using real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care.
Specialties	Cardiology, Radiology	Cardiology, Emergency Medicine, Hospital Medicine
Key Features (Examples)	AI-enabled CCTA analysis, Near real-time, point-of-care assessment, Detection and quantification of coronary plaque	AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection, Real-time disease detection from electrocardiograms, Mobile-based alerts and notifications

Videos

Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and Viz HCM.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac conditions do these AI tools address?

Salix Coronary Plaque is designed for the assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the diagnosis of coronary artery disease. Viz HCM uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM).

What type of patient data is required for each tool's analysis?

Salix Coronary Plaque analyzes CCTA scans to provide its assessment of coronary artery plaque and stenosis. Viz HCM utilizes real-time 12-lead ECG analysis for the detection of suspected Hypertrophic Cardiomyopathy.

How do the reimbursement models and rates compare for using Salix Coronary Plaque versus Viz HCM?

Salix Coronary Plaque operates on a per-scan assessment model with a US CPT reimbursement rate of US$950 per assessment, effective January 1, 2026. Viz HCM is subscription-based for hospitals and health systems, with CMS reimbursement available for CPT codes 0764T and 0765T at a national payment rate of $128.90, effective January 1, 2025.

How do these tools integrate into existing clinical workflows and IT infrastructure?

Salix Coronary Plaque is a web-based, cloud deployment software that provides near real-time, point-of-care assessment. Viz HCM is a cloud-based platform designed for seamless integration with existing clinical workflows, EHR, and PACS systems, providing real-time alerts and notifications.

What are the primary functionalities and benefits each tool offers to a cardiology practice?

Salix Coronary Plaque offers AI-enabled CCTA analysis for detection and quantification of coronary plaque, identification of high-risk plaque features, stenosis assessment, and automated report generation. Viz HCM provides AI-powered ECG analysis for HCM detection, real-time mobile alerts to multidisciplinary care teams, automated patient direction to specialists, and aims to reduce time to diagnosis and treatment for HCM.

Which medical specialties are the primary users or beneficiaries of each AI tool?

Salix Coronary Plaque is primarily for Cardiology and Radiology specialties. Viz HCM is designed for Cardiology, Emergency Medicine, and Hospital Medicine specialties.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Salix Coronary Plaque or Viz HCM

Backers

Who funded each tool's parent company.

Viz HCM

Scale Venture Partners